Table 2.
Diff | Twin |
Case-control |
||||||
---|---|---|---|---|---|---|---|---|
P < 0.05 |
P < 1 × 10−6 |
P < 0.05 |
P < 1 × 10−6 |
|||||
t-testa | Wilcoxb | t-testa | Wilcoxb | t-testc | Wilcoxd | t-testc | Wilcoxd | |
7% | 30 | 30 | 178 | 178 | 37 | 37 | 211 | 211 |
8% | 25 | 25 | 145 | 149 | 30 | 30 | 169 | 169 |
9% | 20 | 20 | 117 | 117 | 24 | 24 | 137 | 137 |
10% | 17 | 18 | 98 | 102 | 20 | 21 | 112 | 110 |
11% | 15 | 15 | 81 | 83 | 17 | 18 | 96 | 95 |
12% | 13 | 13 | 71 | 71 | 15 | 16 | 80 | 80 |
13% | 11 | 12 | 63 | 69 | 13 | 13 | 70 | 70 |
14% | 10 | 11 | 55 | 62 | 11 | 13 | 61 | 63 |
15% | 9 | 10 | 50 | 57 | 10 | 11 | 54 | 57 |
Diff, mean methylation difference between affected and unaffected individuals.
at test, paired t test.
bWilcox, Wilcoxon signed-rank test.
ct test, two-sample t test.
dWilcox, Wilcoxon rank-sum test.